Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,300
Closed -$37K 4689
2020
Q4
$37K Hold
1,300
﹤0.01% 4531
2020
Q3
$29K Hold
1,300
﹤0.01% 4811
2020
Q2
$29K Sell
1,300
-22,900
-95% -$468K ﹤0.01% 5120
2020
Q1
$418K Sell
24,200
-454,800
-95% -$11.6M ﹤0.01% 3735
2019
Q4
$14.6M Buy
+479,000
New +$14.1M 0.01% 1143
2019
Q1
Sell
-6,200
Closed -$145K 7004
2018
Q4
$145K Buy
6,200
+4,000
+182% +$99.4K ﹤0.01% 4791
2018
Q3
$64K Buy
+2,200
New +$66K ﹤0.01% 5906
2017
Q2
Sell
-20,000
Closed -$644K 6629
2017
Q1
$644K Buy
+20,000
New +$594K ﹤0.01% 3154

Other funds holding AXTA

Barclays's AXTA Position: Q1 2026 in Review

Barclays reduced its Axalta (AXTA) stake by 66% in Q1 2026, selling an estimated $6.33M and leaving 104,287 shares worth $2.89M. The position accounts for ﹤0.01% of the portfolio, ranked #2138.

Barclays first reported a position in AXTA in Q4 2014 and has held it in 45 quarters since. The position peaked at $29.6M in Q2 2018. 381 funds tracked by Wall St. Rank hold AXTA as of Q1 2026.

  • Barclays held 104,287 shares of Axalta worth $2.89M as of Q1 2026.
  • Barclays sold 199,450 Axalta shares in Q1 2026, an estimated $6.33M.
  • Axalta made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #2138 holding.
  • Barclays first reported a position in Axalta in Q4 2014 and has held it in 45 quarters since.
  • Barclays's Axalta position peaked at $29.6M in Q2 2018.
  • 381 funds tracked by Wall St. Rank held Axalta as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.